Histopathology of minimal change disease and focal segmental glomerulosclerosis. Histopathology of minimal change disease and focal segmental glomerulosclerosis.

Slides:



Advertisements
Similar presentations
Schematic diagram of a lobe of a normal glomerulus.
Advertisements

Volume 74, Issue 12, Pages (December 2008)
Lymphatic vessels develop during tubulointerstitial fibrosis
The Renal Pathology of Obesity
Clinical Features. This disorder usually presents either with the
Volume 88, Issue 5, Pages (November 2015)
Volume 65, Issue 5, Pages (May 2004)
Figure 1 Pathologic features of obesity-related glomerulopathy (ORG)
Volume 54, Issue 1, Pages (July 1998)
Vivette D D'Agati, MD, Agnes B Fogo, MD, Jan A Bruijn, MD, J
Agnes B. Fogo, MD, Mark A. Lusco, MD, Behzad Najafian, MD, Charles E
Hypertensive nephrosclerosis in African Americans versus Caucasians
American Journal of Kidney Diseases
Morphometric study of arterioles and glomeruli in the aging kidney suggests focal loss of autoregulation1  Gary S. Hill, Didier Heudes, Jean Bariéty 
J.M. Henderson, S. al-Waheeb, A. Weins, S.V. Dandapani, M.R. Pollak 
Volume 53, Issue 5, Pages (May 1998)
Volume 74, Issue 12, Pages (December 2008)
Volume 84, Issue 2, Pages (August 2013)
Kumar Sharma, Ljiljana Paša-Tolić  Kidney International 
Volume 79, Issue 6, Pages (March 2011)
Chronic Pyelonephritis
Update on Focal Segmental Glomerulosclerosis
Volume 54, Issue 5, Pages (November 1998)
Volume 88, Issue 5, Pages (November 2015)
Wilhelm Kriz, Michel Lehir  Kidney International 
The spectrum of kidney biopsy findings in patients with morbid obesity
Volume 71, Issue 1, Pages (January 2007)
Serum-soluble urokinase receptor concentration in primary FSGS
Lupus Nephritis: Proliferative Forms (WHO III, IV)
Lymphatic vessels develop during tubulointerstitial fibrosis
Volume 55, Issue 2, Pages (February 1999)
Volume 83, Issue 6, Pages (June 2013)
M.B. Stokes, A.M. Valeri, G.S. Markowitz, V.D. D'Agati 
Volume 79, Issue 6, Pages (March 2011)
American Journal of Kidney Diseases
Volume 68, Issue 4, Pages (October 2005)
Volume 84, Issue 1, Pages (July 2013)
Synaptopodin expression in idiopathic nephrotic syndrome of childhood
Obesity-related glomerulopathy: An emerging epidemic
HIV-related nephropathy: A South African perspective
Volume 69, Issue 5, Pages (March 2006)
Collapsing Glomerulopathy in Lambda Light Chain Amyloidosis: A Report of 2 Cases  Mazdak A. Khalighi, Alexander J. Gallan, Anthony Chang, Shane M. Meehan 
Volume 71, Issue 12, Pages (June 2007)
AJKD Atlas of Renal Pathology: Focal Segmental Glomerulosclerosis
Immunotactoid Glomerulopathy
Volume 53, Issue 4, Pages (April 1998)
Volume 69, Issue 11, Pages (June 2006)
The NEPTUNE Pathology Scoring System: Examples of descriptors.
Volume 58, Issue 5, Pages (November 2000)
C1q Nephropathy American Journal of Kidney Diseases
Synaptopodin expression is also in cells on Bowman’s capsule in juvenile human kidney. Synaptopodin expression is also in cells on Bowman’s capsule in.
Volume 70, Issue 2, Pages (July 2006)
Volume 67, Issue 3, Pages (March 2005)
Naoki Ikegaya, Akira Hishida, Tatsuo Yamamoto  Kidney International 
Morphologic findings from serial biopsies.
Conditions within the kidney that are conducive to C activation.
The six forms of FSGS. These syndromes include three forms that are most common, including primary FSGS, adaptive FSGS, and APOL1 FSGS. These forms are.
Agnes B. Fogo, MD, Mark A. Lusco, MD, Behzad Najafian, MD, Charles E
Clinical and Pathological Characterization of Mesoamerican Nephropathy: A New Kidney Disease in Central America  Julia Wijkström, MD, Ricardo Leiva, MD,
Volume 58, Issue 1, Pages (July 2000)
Four major patterns of glomerular injury in podocytopathies.
Renal histopathology in anti–glomerular basement membrane (anti-GBM) GN. (A–C) Hematoxylin and eosin–stained sections demonstrating (A) segmental fibrinoid.
Leukocytes in glomeruli of patients with rapidly progressive GN
A glomerulus exhibits mesangiolysis, endothelial denudation, red blood cell congestion, and glomerular basement membrane duplication in this example of.
Collapsing glomerulopathy (CG) and lesions that may resemble CG histologically in renal biopsies from patients with systemic lupus erythematosus. Collapsing.
A glomerulus exhibits global wrinkling and retraction of the glomerular basement membrane and diffuse swelling and hyperplasia of overlying visceral epithelial.
C1q nephropathy: A variant of focal segmental glomerulosclerosis
Incident cases of ESRD secondary to heroin-associated nephropathy, membranoproliferative glomerulonephritis type 1, HIV infection, and focal segmental.
Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis  Eero O. Honkanen, Anna-Maija Teppo, Carola.
Dysproteinemia and the Kidney: Core Curriculum 2019
Presentation transcript:

Histopathology of minimal change disease and focal segmental glomerulosclerosis. Histopathology of minimal change disease and focal segmental glomerulosclerosis. Minimal change disease shows patent glomeruli in the absence of tubulointersitial scarring (silver stain, ×40). The tip lesion represents a focal adhesion of the glomerular tuft to Bowman’s capsule near the proximal tubule takeoff (silver stain, ×400). The most common forms of FSGS seen in adaptive FSGS and across all etiologies of FSGS are the perihilar variant (periodic acid–Schiff stain, ×40) and not otherwise specified pattern (silver stain, ×400). The most distinctive variant is the collapsing variant (collapsing glomerulopathy; silver stain, ×40). A specific instance of collapsing variant can be appreciated in the setting of endothelial tubuloreticular inclusions seen on ultrastructural analysis. These may be observed in high IFN states, including viral infection and exogenous IFN. The red arrowhead indicates the relative response to therapy and propensity of progression of these various forms, with minimal change disease and tip lesion being most responsive and least progressive and collapsing glomerulopathy being most therapy resistant and rapidly progressing. Avi Z. Rosenberg, and Jeffrey B. Kopp CJASN 2017;12:502-517 ©2017 by American Society of Nephrology